Clinical Trial Update: Daily Adaptive Post-Prostatectomy With Stereotactic Ablative Radiotherapy in Patients With Prostate Cancer [NA]

View source ↗

Summary

A Mayo Clinic-sponsored clinical trial is evaluating daily adaptive post-prostatectomy stereotactic ablative radiotherapy for prostate cancer; the study is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Mayo Clinic | Conditions: Malignant Prostate Neoplasm | NA | Status: ACTIVE_NOT_RECRUITING